How Tempus AI Built the Operating System for Precision Medicine

In this episode of The Digital Health Podcast, Lucas and Luna explore how Tempus AI is creating an operating system for precision medicine. They break down the company's $6 billion data flywheel, how it processes genomic and clinical data from over 7 million patients, and why its partnership with Natera is expanding liquid biopsy access. The hosts discuss Tempus's unique business model, its 2024 IPO, and the challenges of integrating AI into clinical workflows. They also touch on the competitive landscape, including rivals like Foundation Medicine and Caris Life Sciences, and what Tempus's approach means for the future of personalized cancer care. A thoughtful look at how data infrastructure is reshaping healthcare. #TempusAI #PrecisionMedicine #DigitalHealth #AIinHealthcare #Genomics #LiquidBiopsy #Natera #CancerCare #HealthTech #IPO #DataFlywheel #FexingoBusiness #BusinessPodcast #HealthcareInnovation #ClinicalAI #FoundationMedicine #CarisLifeSciences #PersonalizedMedicine Keep every episode free: buymeacoffee.com/fexingo